Anatara Lifesciences (ASX:ANR) Provides GaRP-IBS Trial Update
Anatara Lifesciences pauses recruitment for the GaRP-IBS trial, with pivotal results expected in March 2025 and a Share Purchase Plan closing soon.
The Hub of Australian Finance News
Anatara Lifesciences pauses recruitment for the GaRP-IBS trial, with pivotal results expected in March 2025 and a Share Purchase Plan closing soon.
Oncosil Medical Ltd completes a $1 million Share Purchase Plan to finance clinical trials and manufacturing improvements.
Loyal Lithium consolidates the Hidden Lake Lithium Project and welcomes Blair Way to the Board, enhancing strategic capabilities.
TPC Consolidated Limited announces a further extension to its Scheme Implementation Agreement with Wollar Solar Holding Pty Ltd.
Lunnon Metals Limited (ASX:LM8) announces positive drilling results from Lady Herial, confirming significant gold mineralisation and enhancing its resource outlook.
Antipa Minerals Ltd (ASX: AZY) announces new gold targets and positive results from its ongoing exploration programs.
Rio Tinto commits $2.5 billion to expand the Rincon lithium project, enhancing capacity and supporting local economic growth.
Vulcan Energy completes a €100m placement to fund its transformative Lionheart Project, enhancing its lithium and renewable energy initiatives.
Chorus Limited announces a price-quality path decision ensuring revenue certainty for the regulatory period 2025-2028.
DomaCom Limited (ASX:DCL) announces the launch of the Australian Homeowner Equity Fund aimed at improving access to homeownership in Australia.